Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/52006
| Title: | Interleukin-1 antagonism in type 1 diabetes of recent onset: Two multicenter, randomized double-masked, placebo-controlled trials | Authors: | Moran, A. Bundy, B. Becker, D. J. DiMeglio, L. A. Gitelman, S. E. Goland, R. Greenbaum, C. J. Herold, K. C. Marks, J. B. Raskin, P. Sanda, S. Schatz, D. Wherrett, D. Wilson, D. M. Krischer, J. P. Skyler, J. S. Pickersgill, L. De Koning, E. Ziegler, A. G. Böehm, B. Badenhoop, K. Schloot, N. Bak, J. F. Pozzilli, P. Mauricio, D. Donath, M. Y. Castaño, L. Wägner, A. Lervang, H. H. Perrild, H. Mandrup-Poulsen, T. |
UNESCO Clasification: | 32 Ciencias médicas 320502 Endocrinología |
Keywords: | Interleukin-1 Diabetes Trials |
Issue Date: | 2014 | Journal: | Diabetes Technology and Therapeutics | URI: | http://hdl.handle.net/10553/52006 | ISSN: | 1520-9156 | DOI: | 10.1089/dia.2014.1510 | Source: | Diabetes Technology and Therapeutics[ISSN 1520-9156],v. 16 |
| Appears in Collections: | Comentario |
WEB OF SCIENCETM
Citations
3
checked on Nov 17, 2024
Page view(s)
66
checked on Jun 29, 2024
Google ScholarTM
Check
Altmetric
Share
Export metadata
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.